SCHEMBL4627742

SCHEMBL4627742

CCOc1ccc(CC)c(Cc2c[nH]cn2)c1CC.CCc1cc(OCc2ccccc2)cc(CC)c1Cc1c[nH]cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
AOC3 Q16853 1/20 0.35
KDM4E B2RXH2 3/20 0.34
DPYD Q12882 1/20 0.34
LMNA P02545 1/20 0.34
MAPK14 Q16539 1/20 0.34
JAK2 O60674 1/20 0.33
JAK3 P52333 1/20 0.33
MAPK1 P28482 2/20 0.33
NTSR1 P30989 2/20 0.33
ALDH1A1 P00352 2/20 0.33
TRPM8 Q7Z2W7 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2100697 0.89 DPYD (0.41) DPYDTRPM8L3MBTL1SMN1; SMN2BCHE
SCHEMBL4627741 0.86 DPYD (0.36) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL2103538 0.84 MAPT (0.33) AOC3MAPTL3MBTL1
SCHEMBL4628039 0.80 FFAR1 (0.34)
SCHEMBL2102243 0.80 ALOX15 (0.36) KDM4EALDH1A1MAPTL3MBTL1
SCHEMBL4629061 0.79 PDE10A (0.32) KDM4ESMN1; SMN2
SCHEMBL2103242 0.78 MAPT (0.31) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL2104925 0.75 LTA4H (0.37) KDM4ELMNAMAPK1ALDH1A1GAA
SCHEMBL2103689 0.75 KDM4E (0.30) KDM4EL3MBTL1
SCHEMBL3176254 0.71 KDM5B (0.36) JAK2JAK3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1981880-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2008-10-22 EP claimed
WO-2007085556-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-02 WO claimed
EP-1981880-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2008-10-22 EP disclosed
WO-2007085556-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-02 WO disclosed